Objective The aim of this review was to provide an up-to-date summarization of available
Food and Drug Administration-approved vascular closure devices (VCDs) and to analyze …

Abstract Purpose of Review Vascular access and closure is a key part of endovascular
procedures, and access site-related complications are an independent predictor of adverse …

Abstract Objective Vascular closure devices (VCDs) and manual compression (MC) are
used to achieve hemostasis after peripheral vascular interventions (PVIs). We sought to …

Background Complications related to femoral artery access for coronary angiography (CAG)
is a safety concern. Vascular closure devices (VCDs) have been developed to reduce the …

In the past 20 years, numerous percutaneous vascular closure devices have been tested
and compared with manual compression and to surgical cut-down. The suture-mediated …

Background Inadvertent supra-aortic arterial injuries during central venous catheterization
can lead to devastating outcomes. These have been traditionally been managed with open …

Background Chronic kidney disease has been increasing in incidence as a result of
increasing prevalence of diabetes and other risk factors for cardiovascular disease. This …

Background: MynxGrip is a non-suture, balloon catheter-and extravascular sealant-based
vascular closure device designed to help hemostasis after an arterial puncture. This study …

Aim To determine the efficacy of vascular closure devices (VCDs) for hemostasis following
transfemoral percutaneous coronary interventions (PCIs). Methods This two‐group pre–post …

Objectives Manual compression (MC) or vascular closure devices (VCDs) are used to
achieve hemostasis after percutaneous transluminal angioplasty (PTA). However, limited …